conference call

Abacus Global Management will report 2025 results March 12, 2026, and authorized a $20 million share buyback, signaling confidence in its financial position.

Advantage Solutions will release Q4 2025 earnings March 3, 2026, with a conference call at 8:30 a.m. EDT. The company also announced executive leadership changes to boost growth.

Brandywine Realty Trust declares $0.08 quarterly dividend and sets Q1 2026 earnings release for April 22, 2026.

Chicago Atlantic Real Estate Finance will report Q4 2025 earnings on March 12, 2026, with an investor call at 9:00 a.m. ET.

Constellation Software will release Q4 2025 results on March 9, 2026, followed by an investor call on March 10 featuring senior executives.

Lincoln Educational Services will release full-year 2025 financial results on February 23, 2026, followed by an investor conference call at 10:00 a.m. ET.

Nayax will release 2025 financial results March 9, 2026, via English conference call and Hebrew in-person meeting in Israel.

BioLife Solutions will release 2025 financial results and host a conference call on February 26, 2026, discussing earnings and strategic updates for its cell therapy preservation business.

MiMedx will release 2025 financial results February 25, 2026, followed by a webcast and conference call at 4:30 p.m. ET with senior management.

RadNet scheduled Q4 2025 earnings call for March 2, 2026, to discuss financial performance and operational developments across its imaging center network.

Costamare will report Q4 2025 earnings February 18, 2026, and declared quarterly dividends on preferred and common stock, continuing shareholder returns.

Taseko Mines will release 2025 full-year results February 18, discussing Florence Copper ramp-up and Gibraltar production performance.

Dycom Industries will present FY2026 results on March 4, 2026, via conference call at 9:00 a.m. ET, with a press release and Q&A session for investors.

ANI Pharmaceuticals will report 2025 results on February 27, 2026, reaffirming confidence in meeting or exceeding guidance for revenues, EBITDA, and earnings per share.